• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本传统草药真茅抑制流感病毒脱壳。

Maoto, a Traditional Japanese Herbal Medicine, Inhibits Uncoating of Influenza Virus.

作者信息

Masui Shinta, Nabeshima Shigeki, Ajisaka Kazuhiko, Yamauchi Kei, Itoh Ryota, Ishii Kazunari, Soejima Toshinori, Hiromatsu Kenji

机构信息

General Medicine, Fukuoka University Hospital, Fukuoka, Japan.

Department of Microbiology and Immunology, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.

出版信息

Evid Based Complement Alternat Med. 2017;2017:1062065. doi: 10.1155/2017/1062065. Epub 2017 Aug 22.

DOI:10.1155/2017/1062065
PMID:28904550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5585631/
Abstract

We previously reported in randomized controlled trials that maoto, a traditional herbal medicine, showed clinical and virological efficacy for seasonal influenza. In this study, a culturing system for influenza was used to test the effect of maoto. A549 cells in the culture were infected with influenza virus A (PR8) and followed after treatment with maoto; the virus titers in the culture supernatant, intracellular viral proteins, and viral RNA were determined. When infected cells were cultured with maoto for 24 hr, the virus titer and protein were significantly reduced compared with medium only. Other subtypes, A/H3N2, H1N1pdm, and B, were also inhibited by maoto. Proliferation of viral RNA in a 6 hr culture was inhibited by maoto in the early phase, especially in the first 30 min. Focusing on the entry step of the influenza virus, we found that endosomal pH, regulated by vacuolar-type H ATPase (V-ATPase) located in the membrane, was increased when treated with maoto. We also found that uncoating of influenza viruses was also inhibited by maoto, resulting in the increase of the number of virus particles in endosomes. These results strongly suggest that the inhibition of endosomal acidification by maoto results in blocking influenza virus entry to cytoplasm, probably through the inhibition of V-ATPase. The present study provides evidence that supports the clinical use of maoto for the treatment of influenza.

摘要

我们之前在随机对照试验中报告,传统草药麻杏石甘汤对季节性流感具有临床和病毒学疗效。在本研究中,使用流感病毒培养系统来测试麻杏石甘汤的效果。培养中的A549细胞感染甲型流感病毒(PR8),然后用麻杏石甘汤处理;测定培养上清液中的病毒滴度、细胞内病毒蛋白和病毒RNA。当用麻杏石甘汤培养感染细胞24小时时,与仅使用培养基相比,病毒滴度和蛋白显著降低。其他亚型,如A/H3N2、H1N1pdm和B型,也受到麻杏石甘汤的抑制。在6小时培养中,病毒RNA的增殖在早期,尤其是在前30分钟,受到麻杏石甘汤的抑制。关注流感病毒的进入步骤,我们发现,在用麻杏石甘汤处理时,由位于膜上的液泡型H⁺-ATP酶(V-ATP酶)调节的内体pH值升高。我们还发现,麻杏石甘汤也抑制流感病毒的脱壳,导致内体中病毒颗粒数量增加。这些结果有力地表明,麻杏石甘汤对内体酸化的抑制作用可能通过抑制V-ATP酶导致流感病毒进入细胞质受阻。本研究提供了支持麻杏石甘汤用于治疗流感的临床应用的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/bc10ebd67ff7/ECAM2017-1062065.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/e0137fda5bc3/ECAM2017-1062065.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/5448545b9572/ECAM2017-1062065.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/10eeff6d5055/ECAM2017-1062065.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/0ad71b631427/ECAM2017-1062065.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/270de3e0b4cd/ECAM2017-1062065.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/79f6108dab5c/ECAM2017-1062065.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/bc10ebd67ff7/ECAM2017-1062065.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/e0137fda5bc3/ECAM2017-1062065.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/5448545b9572/ECAM2017-1062065.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/10eeff6d5055/ECAM2017-1062065.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/0ad71b631427/ECAM2017-1062065.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/270de3e0b4cd/ECAM2017-1062065.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/79f6108dab5c/ECAM2017-1062065.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc2/5585631/bc10ebd67ff7/ECAM2017-1062065.007.jpg

相似文献

1
Maoto, a Traditional Japanese Herbal Medicine, Inhibits Uncoating of Influenza Virus.日本传统草药真茅抑制流感病毒脱壳。
Evid Based Complement Alternat Med. 2017;2017:1062065. doi: 10.1155/2017/1062065. Epub 2017 Aug 22.
2
Alleviative Effects of a Kampo (a Japanese Herbal) Medicine "Maoto (Ma-Huang-Tang)" on the Early Phase of Influenza Virus Infection and Its Possible Mode of Action.麻黄汤(一种日本草药)对流感病毒感染早期的缓解作用及其可能的作用方式。
Evid Based Complement Alternat Med. 2014;2014:187036. doi: 10.1155/2014/187036. Epub 2014 Mar 20.
3
A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.一项比较传统草药和神经氨酸酶抑制剂治疗季节性流感的随机对照试验。
J Infect Chemother. 2012 Aug;18(4):534-43. doi: 10.1007/s10156-012-0378-7. Epub 2012 Feb 16.
4
Clarithromycin inhibits type a seasonal influenza virus infection in human airway epithelial cells.克拉霉素抑制人呼吸道上皮细胞中 A 型季节性流感病毒的感染。
J Pharmacol Exp Ther. 2010 Apr;333(1):81-90. doi: 10.1124/jpet.109.162149. Epub 2009 Dec 29.
5
The use of maoto (Ma-Huang-Tang), a traditional Japanese Kampo medicine, to alleviate flu symptoms: a systematic review and meta-analysis.使用麻黄汤(Ma-Huang-Tang),一种传统的日本汉方药,缓解流感症状:系统评价和荟萃分析。
BMC Complement Altern Med. 2019 Mar 18;19(1):68. doi: 10.1186/s12906-019-2474-z.
6
Effects of maoto (ma-huang-tang) on host lipid mediator and transcriptome signature in influenza virus infection.麻黄(ma-huang-tang)对流感病毒感染宿主脂质介质和转录组特征的影响。
Sci Rep. 2021 Feb 19;11(1):4232. doi: 10.1038/s41598-021-82707-1.
7
Association between Maoto Use and Hospitalization for Seasonal Influenza in a Nonelderly Cohort in Japan.日本非老年队列中马托使用与季节性流感住院的关联。
Intern Med. 2021;60(21):3401-3408. doi: 10.2169/internalmedicine.6416-20. Epub 2021 Nov 1.
8
Maoto plus neuraminidase inhibitor versus neuraminidase inhibitor alone for reducing hospitalization in older adults with seasonal influenza.茅苍术加神经氨酸酶抑制剂与单独使用神经氨酸酶抑制剂相比,对降低老年季节性流感患者的住院率的影响
Ann Clin Epidemiol. 2022 Jul 8;4(4):120-128. doi: 10.37737/ace.22015. eCollection 2022.
9
Phosphatidylinositol 3-Kinase/Akt and MEK/ERK Signaling Pathways Facilitate Sapovirus Trafficking and Late Endosomal Acidification for Viral Uncoating in LLC-PK Cells.磷脂酰肌醇 3-激酶/ Akt 和 MEK/ ERK 信号通路促进小核糖核酸病毒在 LLC-PK 细胞中的运输和晚期内体酸化,从而实现病毒脱壳。
J Virol. 2018 Nov 27;92(24). doi: 10.1128/JVI.01674-18. Print 2018 Dec 15.
10
Involvement of the vacuolar H(+)-ATPase in animal virus entry.液泡H(+) -ATP酶在动物病毒进入过程中的作用。
J Gen Virol. 1994 Oct;75 ( Pt 10):2595-606. doi: 10.1099/0022-1317-75-10-2595.

引用本文的文献

1
Inhibitory effects of a hot-water extract of cumin fruit on influenza A virus infection.孜然果实热水提取物对甲型流感病毒感染的抑制作用。
PLoS One. 2025 Jun 27;20(6):e0326423. doi: 10.1371/journal.pone.0326423. eCollection 2025.
2
Multiple antiviral mechanisms of Ephedrae Herba and Cinnamomi Cortex against influenza: inhibition of entry and replication.麻黄与肉桂抗流感的多种抗病毒机制:抑制病毒进入与复制。
Microbiol Spectr. 2025 Jun 3;13(6):e0037125. doi: 10.1128/spectrum.00371-25. Epub 2025 Apr 30.
3
The Antiviral Effect of Ephedrine Alkaloids-Free Ephedra Herb Extract, EFE, on Murine Coronavirus Growth in the Lung and Liver of Infected Mice.

本文引用的文献

1
Inhibition of PA endonuclease activity of influenza virus RNA polymerase by Kampo medicines.汉方药对流感病毒RNA聚合酶PA核酸内切酶活性的抑制作用。
Drug Discov Ther. 2016;10(2):109-13. doi: 10.5582/ddt.2016.01010. Epub 2016 Feb 22.
2
Alleviative Effects of a Kampo (a Japanese Herbal) Medicine "Maoto (Ma-Huang-Tang)" on the Early Phase of Influenza Virus Infection and Its Possible Mode of Action.麻黄汤(一种日本草药)对流感病毒感染早期的缓解作用及其可能的作用方式。
Evid Based Complement Alternat Med. 2014;2014:187036. doi: 10.1155/2014/187036. Epub 2014 Mar 20.
3
Glycolytic control of vacuolar-type ATPase activity: a mechanism to regulate influenza viral infection.
不含麻黄碱生物碱的麻黄草提取物(EFE)对感染小鼠肺和肝中鼠冠状病毒生长的抗病毒作用。
Microorganisms. 2025 Apr 6;13(4):830. doi: 10.3390/microorganisms13040830.
4
Antibacterial effects of Kampo products against pneumonia causative bacteria.汉方药产品对肺炎致病菌的抗菌作用。
PLoS One. 2024 Oct 28;19(10):e0312500. doi: 10.1371/journal.pone.0312500. eCollection 2024.
5
Antiviral effect of alkaloids-free Ephedra Herb extract on respiratory syncytial virus infection.无生物碱麻黄草提取物对呼吸道合胞病毒感染的抗病毒作用。
Front Pharmacol. 2024 Jul 5;15:1410470. doi: 10.3389/fphar.2024.1410470. eCollection 2024.
6
The Role of Traditional Chinese Medicine and Chinese Pharmacopoeia in the Evaluation and Treatment of COVID-19.中医药和《中国药典》在评估和治疗 COVID-19 中的作用。
Curr Pharm Des. 2024;30(14):1060-1074. doi: 10.2174/0113816128217263240220060252.
7
Inhibitory effects of senkyuchachosan on SARS-CoV-2 papain-like protease activity in vitro.汉防己甲素对 SARS-CoV-2 木瓜蛋白酶样蛋白酶活性的体外抑制作用。
J Nat Med. 2024 Jun;78(3):784-791. doi: 10.1007/s11418-024-01788-0. Epub 2024 Mar 21.
8
Maoto plus neuraminidase inhibitor versus neuraminidase inhibitor alone for reducing hospitalization in older adults with seasonal influenza.茅苍术加神经氨酸酶抑制剂与单独使用神经氨酸酶抑制剂相比,对降低老年季节性流感患者的住院率的影响
Ann Clin Epidemiol. 2022 Jul 8;4(4):120-128. doi: 10.37737/ace.22015. eCollection 2022.
9
Maoto, a traditional herbal medicine, for post-exposure prophylaxis for Japanese healthcare workers exposed to COVID-19: A single center study.马兜铃,一种传统草药,用于接触 COVID-19 后的日本医护人员暴露后的预防:一项单中心研究。
J Infect Chemother. 2022 Jul;28(7):907-911. doi: 10.1016/j.jiac.2022.03.014. Epub 2022 Mar 21.
10
Ephedrae Herba and Cinnamomi Cortex interactions with G glycoprotein inhibit respiratory syncytial virus infectivity.麻黄和肉桂与 G 糖蛋白相互作用抑制呼吸道合胞病毒感染性。
Commun Biol. 2022 Jan 25;5(1):94. doi: 10.1038/s42003-022-03046-z.
糖酵解控制液泡型 ATP 酶活性:一种调控流感病毒感染的机制。
Virology. 2013 Sep;444(1-2):301-9. doi: 10.1016/j.virol.2013.06.026. Epub 2013 Jul 19.
4
Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses.二苯乙烯苷(一种 v-ATPase 阻断剂)对流感病毒的抑制和组合作用。
Antiviral Res. 2013 Sep;99(3):371-82. doi: 10.1016/j.antiviral.2013.06.014. Epub 2013 Jun 29.
5
A Kampo (traditional Japanese herbal) medicine, Hochuekkito, pretreatment in mice prevented influenza virus replication accompanied with GM-CSF expression and increase in several defensin mRNA levels.一种汉方药(传统日本草药),Hochuekkito,在小鼠中的预处理可防止流感病毒复制,同时伴有 GM-CSF 表达和几种防御素 mRNA 水平的增加。
Pharmacology. 2013;91(5-6):314-21. doi: 10.1159/000350188. Epub 2013 Jun 19.
6
Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09.神经氨酸酶抑制剂治疗甲型流感 A(H1N1)pdm09 危重症患者。
Clin Infect Dis. 2012 Nov;55(9):1198-204. doi: 10.1093/cid/cis636. Epub 2012 Jul 26.
7
A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.一项比较传统草药和神经氨酸酶抑制剂治疗季节性流感的随机对照试验。
J Infect Chemother. 2012 Aug;18(4):534-43. doi: 10.1007/s10156-012-0378-7. Epub 2012 Feb 16.
8
Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza.对奥司他韦耐药的甲型H1N1pdm09流感病毒的社区传播。
N Engl J Med. 2011 Dec 29;365(26):2541-2. doi: 10.1056/NEJMc1111078.
9
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives.2009 年甲型 H1N1 流感大流行期间的抗病毒耐药性:公共卫生、实验室和临床视角。
Lancet Infect Dis. 2012 Mar;12(3):240-8. doi: 10.1016/S1473-3099(11)70318-8. Epub 2011 Dec 18.
10
The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections.细胞液泡型三磷酸腺苷酶的质子转移结构域为治疗甲型流感病毒感染提供了一个靶标。
Br J Pharmacol. 2011 Sep;164(2):344-57. doi: 10.1111/j.1476-5381.2011.01346.x.